1) Lars Schimmöller,
Dirk Blondin,
Christian Arsov,
Robert Rabenalt,
Peter Albers,
Gerald Antoch and Michael Quentin.
MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings.
AJR January 2016; 206 (1):92-99
2) Murphy G,
Haider M,
Ghai S,
Sreeharsha B.
The expanding role of MRI in prostate cancer.
AJR 2013; 201:1229–1238
3) Dickinson L,
Ahmed HU,
Allen C,
et al.
Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection,localization,
and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging 2013; 37:48–58
4) Moore CM,
Robertson NL,
Arsanious N,
Middleton T,
Villers A,
Klotz L,
Taneja SS,
Emberton M.
Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review.
Eur Urol 2013; 63:125–140
5) M.
Minhaj Siddiqui,
MD; Soroush Rais-Bahrami,
MD; Baris Turkbey,
MD; Arvin K.
George,
MD; Jason Rothwax,
BS; Nabeel Shakir,
BS; Chinonyerem Okoro,
BS; Dima Raskolnikov,
BS; Howard L.
Parnes,
MD; W.
Marston Linehan,
MD; Maria J.
Merino,
MD; Richard M.
Simon,
DSc; Peter L.
Choyke,
MD; Bradford J.
Wood,
MD; Peter A.
Pinto,
MD.
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
JAMA 2015; 313:390–397
6) Christian Arsov,
Robert Rabenalt,
Dirk Blondin,
Michael Quentin,
Andreas Hiester,
Erhard Godehardt,
Helmut E.
Gabbert,
Nikolaus Becker,
Gerald Antoch ,
Peter Albers and Lars Schimmöller.
Prospective Randomized Trial Comparing Magnetic Resonance Imaging (MRI)-guided In-bore Biopsy to MRI-ultrasound Fusion and Transrectal Ultrasound-guided Prostate Biopsy in Patients with Prior Negative Biopsies.
European Urology,
Volume 68 (4),
October 2015,
713-720
7) Tobias Penzkofer,
MD Kemal Tuncali,
MD Andriy Fedorov,
PhD Sang-Eun Song,
PhD Junichi Tokuda,
PhD Fiona M.
Fennessy,
MB,
BCh,
BAO,
PhD Mark G.
Vangel,
PhD Adam S.
Kibel,
MD Robert V.
Mulkern,
PhD William M.
Wells,
PhDNobuhiko Hata,
PhD Clare M.
C.
Tempany,
MB,
BCh,
BAO.
Transperineal In-Bore 3-T MR Imaging–guided Prostate Biopsy: A Prospective Clinical Observational Study
8) Derek W.Cool,
Xuli Zhang,
Cesare Romagnoli,
Jonathan I.
Izawa,
Walter M.
Romano and Aaron Fenster Evaluation of MRI-TRUS Fusion Versus Cognitive Registration Accuracy for MRI-Targeted,
TRUS-Guided Prostate Biopsy.
AJR 2015; 204:83–91
9) Frantz DD,
Wiles AD,
Leis SE,
Kirsch SR.
Accuracy assessment protocols for electromagnetic tracking systems.
Phys Med Biol.
2003 Jul 21;48(14):2241-51.
10) Bradford J.
Wood,
MD,
Hui Zhang,
PhD,
Amir Durrani,
BS,
Neil Glossop,
PhD,
Sohan Ranjan,MS,
David Lindisch,
RT,
Eliott Levy,
MD,
Filip Banovac,
MD,
Joern Borgert,
PhD,
Sascha Krueger,
PhD,
Jochen Kruecker,
PhD,
Anand Viswanathan,
MS,
and Kevin Cleary,
PhD.
Navigation with Electromagnetic Tracking for Interventional Radiology Procedures,
A Feasibility Study.
J Vasc Interv Radiol 2005 April,
Volume 16 (4): 493-505
11) George C.
Kagadis,
Konstantinos Katsanos,
Dimitris Karnabatidis,
George Loudos,
George C.
Nikiforidis,
and William R.
Hendee.
Emerging technologies for image guidance and device navigation in interventional radiology.
Med Phys.
2012 Sep;39(9):5768-81.
12) Pokorny MR,
de Rooij M,
Duncan E,
et al.
Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Eur Urol 2014; 66:22–29
13) Moore CM,
Robertson NL,
Arsanious N,
Middleton T,
Villers A,
Klotz L,
Taneja SS,
Emberton M.
Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review.
Eur Urol 2013; 63:125–140
14) Rais-Bahrami S,
Siddiqui MM,
Vourganti S,
Turkbey B,
Rastinehad AR,
Stamatakis L,
Truong H,
Walton-Diaz A,
Hoang AN,
Nix JW,
Merino MJ,
Wood BJ,
Simon RM,
Choyke PL,
Pinto PA Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies.
BJU Int.
2015 Mar;115(3):381-8.
15) Thestrup KC,
Logager V,
Baslev I,
Møller JM,
Hansen RH,
Thomsen HS.
Biparametric versus multiparametric MRI in the diagnosis of prostate cancer.
Acta Radiol Open.
2016 Aug 17;5(8)1-8